Alzheimer's Dementia and Binding to Alpha2 Adrenoreceptors in Platelets

Abraham Adunsky, Moshe Hershkowitz, Marian Rabinowitz

Research output: Contribution to journalArticlepeer-review


Seventy‐five patients with probable Alzheimer's disease were screened for binding of alpha2 receptors (A2R) to their platelet membranes; the results were compared with 51 age‐ and sex‐matched controls. Receptor binding assays were performed using [3H] Yohimbine as the radioligand. The results showed a higher binding capacity in the demented population as compared to the control group (2.18 ± 0.15 fmol/mg protein, as compared to 1.73 ± 0.13, P < 0.03). This increased binding to platelets in the demented patients was more prominent in demented females: 34% higher binding as compared with female controls (2.06 ± 0.5 vs 1.54 ± 0.04). The difference between demented and normal males was less (2.34 ± 0.05 vs 1.88 ± 0.05). The results indicate an involvement of the A2R system, either primarily or secondarily, in the disease process. Since there is an overlap between results from the patients with Alzheimer's disease and the normal subjects, A2R may serve as only a supportive marker for Alzheimer's disease.

Original languageEnglish
Pages (from-to)741-744
Number of pages4
JournalJournal of the American Geriatrics Society
Issue number8
StatePublished - Aug 1989


Dive into the research topics of 'Alzheimer's Dementia and Binding to Alpha2 Adrenoreceptors in Platelets'. Together they form a unique fingerprint.

Cite this